2015-2019 Orthopedics Market Consolidation: Who will not survive?

July 2015 | 136 pages | ID: 2C43F699E25EN
Venture Planning Group

Abstracts

Will the $50 billion global orthopedics industry consolidate, decentralize, or undergo a bimodal transformation?

How will the current trends affect the major market segments?

Which companies will enter the market and which will not survive?

This report provides a worldwide strategic overview of the orthopedics market, including Analysis of such market segment as:

• reconstructive devices
• fracture fixation products
• arthroscopy
• soft tissue repair
• spinal implants and instrumentation
• bone growth stimulators
• power instruments
• casting materials
• operating room ancillary products and major geographic regions, including U.S., Europe, and Asia.

In addition, the report presents a concise review of the major U.S. and international trends with potentially significant impact on the orthopedics market during the next five years, including industry consolidation, market globalization, environmental regulations, etc.

The company profiles include:

• Business, new product development and marketing strategies.
• Anticipated acquisitions and joint ventures.
• Major strengths and weaknesses.
• The U.S. and international sales force size.
• Distribution approaches.
• Major promotional tactics.
• Internally developed and acquired technologies.
• Technical expertise in biotechnology, engineering and other pertinent fields.

Contains 136 pages and 3 tables

Contents

I. MARKET OVERVIEW

    a. U.S.A
  1. Business Environment
    a. Health Care Expenditures
    b. Cost Consciousness
    c. Industry Consolidation
    d. Managed Care
    e. Hospitals
    f. Admissions
    g. Length of Stay
    h. Industry Diversification
    i. Physician Demographics
    j. Population Aging
    b. Other Countries

II. MARKET SIZE AND GROWTH

    a. Major Market Segments
    b. Major Geographic Regions

III. EMERGING TECHNOLOGIES

    a. Overview
    b. Resorbables
    c. Bone Substitutes
    d. Osteoinductive Agents/
Bone Graft Factors
    e. Soft Tissue Repair And Replacement
    f. Viscoelastics
    g. Osteoporosis Therapies

IV. LEADING ORTHOPEDICS COMPANIES STRATEGIC DIRECTIONS

Business, new product development and marketing strategies
Anticipated acquisitions, joint ventures and marketing strategies
Major strengths and weaknesses

V. LEADING ORTHOPEDICS COMPANIES MARKETING TACTICS

The U.S. and international sales force size
Distribution approaches
Major promotional tactics

VI. LEADING ORTHOPEDICS COMPANIES TECHNOLOGICAL KNOW-HOW INTERNALLY DEVELOPED AND ACQUIRED TECHNOLOGIES

Technical expertise in biotechnology, engineering and other pertinent fields